Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:56PM EDT. Market open.
| Previous close | 135.04 |
| Open | 135.10 |
| Bid | 134.89 x 100 |
| Ask | 135.38 x 100 |
| Day's range | 132.90 - 135.63 |
| 52-week range | 55.25 - 159.89 |
| Volume | |
| Avg. volume | 882,670 |
| Market cap | 12.765B |
| Beta (5Y monthly) | 0.95 |
| PE ratio (TTM) | 314.07 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Earnings Beat: Sarepta Therapeutics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) just released its quarterly report and things are looking bullish. It was a...
- Zacks
Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Insider Monkey
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript May 1, 2024 Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $-0.11. Sarepta Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome […]
© 2024 Yahoo. All rights reserved.